Taking the physician's workflow into account can pave the way for greater acceptance of digital therapeutics.
Tracey Dodenhoff, CEO of Medly Therapeutics, discusses how considering the physician in the digital therapeutics development can help their uptake and acceptance.
FDA issues de novo clearance for SonoMotion’s Stone Clear device, for kidney stone treatment
Stone Clear is the first and only device cleared by the FDA that uses external ultrasound pulses to facilitate passage of post-lithotripsy kidney stone fragments without surgery.